Roche’s vision loss therapy faricimab extends time between treatments by up to four months
admin 12th February 2021 Uncategorised 0Results from four Phase III studies demonstrated non-inferior vision gains with extended dosing schedule
More: Roche’s vision loss therapy faricimab extends time between treatments by up to four months
Source: News